Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal.
Prostate cancer is a significant cause of morbidity and mortality. In Portugal alone, according to a study published in 2003, the rate of new prostate cancer cases were 53 per 100,000 men (in 2000), with an age-standardized mortality rate of about 28 per 100,000 (in 1995). Multiple bone metastases a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ordem dos Médicos
2007-03-01
|
| Series: | Acta Médica Portuguesa |
| Online Access: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/972 |
| _version_ | 1797996303345516544 |
|---|---|
| author | Ana Macedo António Araújo Fernando Carvalho Melo Garção Nunes Guilhermina Cantinho Inêz Amorin |
| author_facet | Ana Macedo António Araújo Fernando Carvalho Melo Garção Nunes Guilhermina Cantinho Inêz Amorin |
| author_sort | Ana Macedo |
| collection | DOAJ |
| description | Prostate cancer is a significant cause of morbidity and mortality. In Portugal alone, according to a study published in 2003, the rate of new prostate cancer cases were 53 per 100,000 men (in 2000), with an age-standardized mortality rate of about 28 per 100,000 (in 1995). Multiple bone metastases are one of the major complications of advanced prostate cancer. Samarium-EDTMP showed to be a safe and effective alternative for palliative treatment of bone metastases. The goal of this economic study is to assess the cost-effectiveness of Samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal.Cost-effectiveness study that compares the expected direct costs to the National Health System of managing patients with painful multiple bone metastases with Samarium-153-EDTMP versus conventional pain therapy, in Portugal, in a 4-moths period.The total direct 4 months cost was 2,311.91 euro for a patient treated with Samarium-153-EDTMP versus 2,450.74 euro for a patient under standard treatment. According to the model a patient treated with Samarium-153-EDTMP represents a 138.83 euros saving.Samarium-153-EDTMP was not only a very effective therapeutic option but also an option with less cost than the conventional pain therapy, in patients with pain due to multiple bone metastases, in Portugal. |
| first_indexed | 2024-04-11T10:15:12Z |
| format | Article |
| id | doaj.art-9e59369fb9584849894e0b81f4d73d45 |
| institution | Directory Open Access Journal |
| issn | 0870-399X 1646-0758 |
| language | English |
| last_indexed | 2024-04-11T10:15:12Z |
| publishDate | 2007-03-01 |
| publisher | Ordem dos Médicos |
| record_format | Article |
| series | Acta Médica Portuguesa |
| spelling | doaj.art-9e59369fb9584849894e0b81f4d73d452022-12-22T04:29:59ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07582007-03-0119510.20344/amp.972Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal.Ana Macedo0António AraújoFernando Carvalho MeloGarção NunesGuilhermina CantinhoInêz AmorinKeypoint, Serviço de Urologia do Hospital Curry Cabral, Atomedical, Lisboa, Portugal.Prostate cancer is a significant cause of morbidity and mortality. In Portugal alone, according to a study published in 2003, the rate of new prostate cancer cases were 53 per 100,000 men (in 2000), with an age-standardized mortality rate of about 28 per 100,000 (in 1995). Multiple bone metastases are one of the major complications of advanced prostate cancer. Samarium-EDTMP showed to be a safe and effective alternative for palliative treatment of bone metastases. The goal of this economic study is to assess the cost-effectiveness of Samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal.Cost-effectiveness study that compares the expected direct costs to the National Health System of managing patients with painful multiple bone metastases with Samarium-153-EDTMP versus conventional pain therapy, in Portugal, in a 4-moths period.The total direct 4 months cost was 2,311.91 euro for a patient treated with Samarium-153-EDTMP versus 2,450.74 euro for a patient under standard treatment. According to the model a patient treated with Samarium-153-EDTMP represents a 138.83 euros saving.Samarium-153-EDTMP was not only a very effective therapeutic option but also an option with less cost than the conventional pain therapy, in patients with pain due to multiple bone metastases, in Portugal.https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/972 |
| spellingShingle | Ana Macedo António Araújo Fernando Carvalho Melo Garção Nunes Guilhermina Cantinho Inêz Amorin Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal. Acta Médica Portuguesa |
| title | Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal. |
| title_full | Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal. |
| title_fullStr | Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal. |
| title_full_unstemmed | Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal. |
| title_short | Análise custo-efectividade do samário-153-EDTMP versus terapêutica convencional da dor em doentes com metástases ósseas múltiplas dolorosas em Portugal. |
| title_sort | analise custo efectividade do samario 153 edtmp versus terapeutica convencional da dor em doentes com metastases osseas multiplas dolorosas em portugal |
| url | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/972 |
| work_keys_str_mv | AT anamacedo analisecustoefectividadedosamario153edtmpversusterapeuticaconvencionaldadoremdoentescommetastasesosseasmultiplasdolorosasemportugal AT antonioaraujo analisecustoefectividadedosamario153edtmpversusterapeuticaconvencionaldadoremdoentescommetastasesosseasmultiplasdolorosasemportugal AT fernandocarvalhomelo analisecustoefectividadedosamario153edtmpversusterapeuticaconvencionaldadoremdoentescommetastasesosseasmultiplasdolorosasemportugal AT garcaonunes analisecustoefectividadedosamario153edtmpversusterapeuticaconvencionaldadoremdoentescommetastasesosseasmultiplasdolorosasemportugal AT guilherminacantinho analisecustoefectividadedosamario153edtmpversusterapeuticaconvencionaldadoremdoentescommetastasesosseasmultiplasdolorosasemportugal AT inezamorin analisecustoefectividadedosamario153edtmpversusterapeuticaconvencionaldadoremdoentescommetastasesosseasmultiplasdolorosasemportugal |